Jaime Deville, MD
Jaime Deville, MD (Faculty Mentor) is Clinical Professor of Pediatrics and Infectious Diseases at UCLA Children’s Hospital. He serves as Principal Investigator at UCLA for several NIH-funded clinical trial networks, including the NIAID Division of Clinical Research Influenza Research Network, the Adolescent Trials Network, the INSIGHT Network and leads the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) CRS. A graduate of UPCH/Peru, Dr. Deville continues his involvement in pediatric HIV research in Peru, collaborating with local investigators on clinical trials for treatment of pediatric HIV and opportunistic infections.
Antiretroviral therapy in pediatric HIV
Outcomes of congenital and pediatric HIV infection in Peru
Disclosure of HIV status to HIV-infected children
Saez-LLorens X., Castano E., Rathore M., Church J. Deville J., Gaur A., Estripeaut D., White K., Kearney B., Arterburn S., Enejosa J.V., Cheng A.K., Chuck S.L., Rhee M.L. A Randomized, Open-Label Study of the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir disproxil fumarate (DF) in HIV-1 infected children with virologic suppression. Pediatr Infect Dis J. 2015 Apr;34(4):376-82.
Benjamin D.K., Deville J.G., Azie N., Kovanda L., Arrieta A. Safety and Pharmacokinetic Profiles of Repeated-Dose Micafungin in Children and Adolescents Treated for Invasive Candidiasis. Pediatr Infect Dis J. 2013 Nov;32(11): e419-25.
Deville J.G., Equils O., Huang D.B., Ang J.Y. The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections. Clinical Pediatrics 2011 Nov;50(11):1064-7.
Deville J.G., Goldfarb J., Kaplan S., Equils O., Huang D., Ang J., Salazar J. The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin. Journal of Antimicrobial Chemotherapy 2010 Oct;65(10):2267-70.
Brogly S.B., Foca M., Deville J.G., Mirochnick M., Scott G.B., Mofenson L.M., Read J.S., Viani R.M., Burchett S.K., Cooper E.R., Browning R., Shapiro D.E. Potential Confounding of the Association Between Exposure to Nucleoside Analogues and Mitochondrial Dysfunction in HIV-uninfected and Undeterminate Infants. Journal of the Acquired Immune Deficiency Syndrome. 2010 Jan 1;53(1):154-7.
Applications for the 2024-25 Fellowship class are now being accepted. The priority application deadline for the 2024-25 Fellowship class is February 16, 2024.